Nomura Holdings’s Caribou Biosciences CRBU Stock Holding History

Nomura Holdings’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-59,364	Closed	-$116K	–	2215
2024 Q3	$116K	Buy	+59,364	New	+$122K	﹤0.01%	1433

Other funds holding CRBU

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

EWM

Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nomura Holdings's CRBU Position: Q4 2024 in Review

Nomura Holdings sold out of Caribou Biosciences (CRBU) in Q4 2024, closing a stake of 59,364 shares — an estimated $116K sold.

Nomura Holdings first reported a position in CRBU in Q3 2024 and held it in 1 quarter. The position peaked at $116K in Q3 2024. 133 funds tracked by Wall St. Rank hold CRBU as of Q4 2024.

Nomura Holdings reported no remaining Caribou Biosciences position as of Q4 2024 after selling out during the quarter.
Nomura Holdings sold 59,364 Caribou Biosciences shares in Q4 2024, an estimated $116K.
Nomura Holdings first reported a position in Caribou Biosciences in Q3 2024 and held it in 1 quarter.
Nomura Holdings's Caribou Biosciences position peaked at $116K in Q3 2024.
133 funds tracked by Wall St. Rank held Caribou Biosciences as of Q4 2024.

Based on Nomura Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.